MARINA BIOTECH INC COM STK (DE)
MRNA
MRNA was delisted on the 1st of February, 2012.
1 hedge funds and large institutions have $0 invested in MARINA BIOTECH INC COM STK (DE) in 2021 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less capital invested
Capital invested by funds: $45K → $0 (-$45K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Sonora Investment Management
Tucson,
Arizona
|
-$45K |
MRNA Hedge Fund Activity: Q2 2021 in Review
1 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in MARINA BIOTECH INC COM STK (DE) (MRNA) for Q2 2021, worth a combined $0 — down 100% from $45K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of MRNA and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Sonora Investment Management, exiting entirely with an estimated $45K sold.
- 1 institutional investor held MARINA BIOTECH INC COM STK (DE) (MRNA) as of Q2 2021, down from 2 in Q1 2021.
- Funds reported $0 of MARINA BIOTECH INC COM STK (DE) stock for Q2 2021, down 100% quarter-over-quarter.
- 0 funds opened new MARINA BIOTECH INC COM STK (DE) positions in Q2 2021 and 1 closed out, a net change of -1 holder.
- The largest MARINA BIOTECH INC COM STK (DE) seller in Q2 2021 was Sonora Investment Management, an estimated $45K sold.
Based on aggregated 13F filings for Q2 2021.